Obesity is high and holding steady in the U.S. About 4 in 10 Americans have obesity overall and about 1 in 10 have severe ...

The U.S. obesity rate is about 40%, according to a 2021-2023 survey of about 6,000 people. Nearly 1 in 10 of those surveyed ...

In a high-profile showdown Tuesday with Sen. Bernie Sanders’ Senate health committee, Novo Nordisk CEO Lars Fruergaard ...

Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new ...

You can use Wegovy (semaglutide) as long as needed for weight loss. This is if your doctor agrees it’s safe for you and you’re able to tolerate Wegovy’s side effects. This article looks at ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new formulation ...

Kim Jong-un's army ready to confront the United States Vinegar and baking soda: A cleaning hack or just a bunch of fizz? Cappadocia beckons with its geographical wonders The highs & lows of the ...

Bill Coombs, who lives in Boston’s South End, has lost 28 pounds since he started using the obesity drug Wegovy. But when he went to refill his prescription in late August, things didn’t go as ...

Novo Nordisk, the Danish company behind Wegovy – also sold as Ozempic to control diabetes – also has a pill going through medical trials. Dr Henrik Sillesen, Airfinity’s chief medical ...

Share on Pinterest GLP-1 drugs like Ozempic and Wegovy may help reduce risks from severe COVID-19 for people living with overweight or obesity. Dima Berlini/Getty Images A new study has found that ...

(NEXSTAR) – A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t adequately warn her, or other patients, of the serious side ...